BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30077749)

  • 1. Fluciclovine, Anti-1-Amino-3-[
    Nguyen QD; Amato R; Riascos R; Ballester L; Tandon N; Blanco A; Esquenazi Y
    World Neurosurg; 2018 Nov; 119():132-136. PubMed ID: 30077749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal Meningiomas Mimicking Dural-Based Intracranial Metastases at 18F-Fluciclovine PET/CT.
    Manganaro MS; Millet JD; Manganaro MS
    Clin Nucl Med; 2019 Jul; 44(7):594-595. PubMed ID: 31107759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.
    Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):206-13. PubMed ID: 27511856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
    Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Additional Primary Neoplasms on
    Parihar AS; Schmidt LR; Dehdashti F; Wahl RL
    J Nucl Med; 2022 May; 63(5):713-719. PubMed ID: 34413144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan.
    Gill HS; Tade F; Greenwald DT; Yonover PM; Savir-Baruch B
    Clin Nucl Med; 2018 Jan; 43(1):23-24. PubMed ID: 29189374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental Spinal Meningioma on an 18F-Fluciclovine PET/CT.
    Marcus C; Baugnon K; Schuster DM
    Clin Nucl Med; 2022 Mar; 47(3):e313-e314. PubMed ID: 35025777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
    Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
    J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer.
    Baiomy A; Schellingerhout D; Chapin BF; Weinberg JS; Raza SM; Macapinlac H; Ravizzini G
    Nucl Med Commun; 2021 Jul; 42(7):755-762. PubMed ID: 33741867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous Malignancies Identified by
    Hoyle JM; Lenzie A; Galgano SJ; McConathy JE; Rais-Bahrami S; Nix JW; McDonald AM
    Clin Genitourin Cancer; 2021 Feb; 19(1):e37-e40. PubMed ID: 32771333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best Practices for
    Tade FI; Sajdak RA; Gabriel M; Wagner RH; Savir-Baruch B
    J Nucl Med Technol; 2019 Dec; 47(4):282-287. PubMed ID: 31182661
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of
    Gusman M; Aminsharifi JA; Peacock JG; Anderson SB; Clemenshaw MN; Banks KP
    Radiographics; 2019; 39(3):822-841. PubMed ID: 31059396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.
    Chau A; Gardiner P; Colletti PM; Jadvar H
    Clin Nucl Med; 2018 Jul; 43(7):e226-e231. PubMed ID: 29762238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraprostatic Uptake of
    Robertson MS; Sakellis CG; Hyun H; Jacene HA
    AJR Am J Roentgenol; 2020 Mar; 214(3):641-648. PubMed ID: 31939697
    [No Abstract]   [Full Text] [Related]  

  • 15. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on
    Parent EE; Schuster DM
    J Nucl Med; 2018 May; 59(5):733-739. PubMed ID: 29523631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of Prostate Cancer Using Fluciclovine.
    Savir-Baruch B; Zanoni L; Schuster DM
    PET Clin; 2017 Apr; 12(2):145-157. PubMed ID: 28267449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental detection of oropharyngeal cancer with fluciclovine PET.
    Jethanandani A; Chen MM; Gule-Monroe MK; Morrison WH; Lai SY; Johnson JM
    Head Neck; 2019 Aug; 41(8):E141-E145. PubMed ID: 31046173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer.
    Savir-Baruch B; Banks KP; McConathy JE; Molchanova-Cook OP; Parent EE; Takalkar A; Tulchinsky M; Yu JQ; Subramaniam RM; Schuster DM
    Clin Nucl Med; 2018 Dec; 43(12):909-917. PubMed ID: 30325827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (
    Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O; Chau A; Ward P; Goodman MM; Fanti S; Schuster DM; Willoch F
    J Urol; 2017 Mar; 197(3 Pt 1):676-683. PubMed ID: 27746282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.